Background: Hyperglycemia is always seen amongst acute intra-cerebral hemorrhage (ICH) and usually has been reported in literature and studied in relation to mortality and poor recovery. However, literature specific t...Background: Hyperglycemia is always seen amongst acute intra-cerebral hemorrhage (ICH) and usually has been reported in literature and studied in relation to mortality and poor recovery. However, literature specific to stroke-associated pneumonia (SAP) on this topic is very small. Further, how to differentiate the predictive value of hyperglycemia with and without abnormal HbA1C in such patients is still a matter of debate and no universal consensus. We evaluated hyperglycemia as a marker for SAP in patients with ICH to assess its usefulness as a potential predictor. Materials and methods: Clinical characteristics for a sample of 551 patients with acute ICH were collected from the Beijing Tiantan Hospital of Capital Medical University, Beijing, China. Possible associated risk factors of SAP were reviewed. Hyperglycemia and HbA1C on admission were the main hypothetic predictor, SAP occurring within the first 7 days is the primary outcome. Results: The cohort study includes 551 hospitalized patients. The prevalence of hyperglycemia was 52.5% and SAP occurred in 147 (26.7%). The incidence of SAP was higher in the group with hyperglycemia than those without hyperglycemia (37.7% versus 14.5%, p 6.5) (OR, 1.57;95%CI, 0.81 - 3.23) had not been shown to be associated with SAP. Conclusions: In this hospital-based cohort of patients presenting with acute intra-hemorrhage, hyperglycemia on admission was associated significantly with SAP. The association was stronger for hyperglycemia with normal HgbA1C than for hyperglycemia with high HgbA1C. Hyperglycemia with normal HgbA1C might be a more sensitive predictor of early acute complication, such as SAP.展开更多
目的:系统分析目前中医药辅助治疗卒中相关性肺炎(SAP)的随机对照试验(RCT)中结局指标的应用现状,为临床研究提供依据。方法:检索中国知网数据库、万方数据库、维普数据库、中国生物医学文献服务系统、PubMed、Web of Science、Cochrane...目的:系统分析目前中医药辅助治疗卒中相关性肺炎(SAP)的随机对照试验(RCT)中结局指标的应用现状,为临床研究提供依据。方法:检索中国知网数据库、万方数据库、维普数据库、中国生物医学文献服务系统、PubMed、Web of Science、Cochrane Library、EMbase以及中国临床试验注册中心、ClinicalTrials.gov,筛选出中医药辅助治疗SAP的RCTs,进行偏移风险评价,并描述性统计分析结局指标使用情况。结果:初步筛选文献9804篇,最终纳入31篇(其中1篇为试验方案),共提取到92种结局指标,主要概括为8类,根据频次由高到低依次为理化检测(110次)、临床疗效时间(48次)、临床疗效率(34次)、生活质量评价(24次)、症状体征(17次)、安全性评价(16次)、中医证候疗效(3次)、其他指标(3次)。结论:中医药辅助治疗SAP的RCTs结局指标遴选存在主次不分,重视替代指标、轻视终点结局指标,复合结局指标评定标准不规范,对中医证候疗效评价、经济学评估和安全性结局指标关注不足等问题。展开更多
文摘Background: Hyperglycemia is always seen amongst acute intra-cerebral hemorrhage (ICH) and usually has been reported in literature and studied in relation to mortality and poor recovery. However, literature specific to stroke-associated pneumonia (SAP) on this topic is very small. Further, how to differentiate the predictive value of hyperglycemia with and without abnormal HbA1C in such patients is still a matter of debate and no universal consensus. We evaluated hyperglycemia as a marker for SAP in patients with ICH to assess its usefulness as a potential predictor. Materials and methods: Clinical characteristics for a sample of 551 patients with acute ICH were collected from the Beijing Tiantan Hospital of Capital Medical University, Beijing, China. Possible associated risk factors of SAP were reviewed. Hyperglycemia and HbA1C on admission were the main hypothetic predictor, SAP occurring within the first 7 days is the primary outcome. Results: The cohort study includes 551 hospitalized patients. The prevalence of hyperglycemia was 52.5% and SAP occurred in 147 (26.7%). The incidence of SAP was higher in the group with hyperglycemia than those without hyperglycemia (37.7% versus 14.5%, p 6.5) (OR, 1.57;95%CI, 0.81 - 3.23) had not been shown to be associated with SAP. Conclusions: In this hospital-based cohort of patients presenting with acute intra-hemorrhage, hyperglycemia on admission was associated significantly with SAP. The association was stronger for hyperglycemia with normal HgbA1C than for hyperglycemia with high HgbA1C. Hyperglycemia with normal HgbA1C might be a more sensitive predictor of early acute complication, such as SAP.
文摘目的:系统分析目前中医药辅助治疗卒中相关性肺炎(SAP)的随机对照试验(RCT)中结局指标的应用现状,为临床研究提供依据。方法:检索中国知网数据库、万方数据库、维普数据库、中国生物医学文献服务系统、PubMed、Web of Science、Cochrane Library、EMbase以及中国临床试验注册中心、ClinicalTrials.gov,筛选出中医药辅助治疗SAP的RCTs,进行偏移风险评价,并描述性统计分析结局指标使用情况。结果:初步筛选文献9804篇,最终纳入31篇(其中1篇为试验方案),共提取到92种结局指标,主要概括为8类,根据频次由高到低依次为理化检测(110次)、临床疗效时间(48次)、临床疗效率(34次)、生活质量评价(24次)、症状体征(17次)、安全性评价(16次)、中医证候疗效(3次)、其他指标(3次)。结论:中医药辅助治疗SAP的RCTs结局指标遴选存在主次不分,重视替代指标、轻视终点结局指标,复合结局指标评定标准不规范,对中医证候疗效评价、经济学评估和安全性结局指标关注不足等问题。
